High levels of fetal DNA are associated with increased risk of spontaneous preterm delivery

Prenatal Diagnosis

Volumn 32, Issue 9, 2012, Pages 840-845

  Jakobsen, Tanja R ^a   Clausen, Frederik B ^a   Rode, Line ^a   Dziegiel, Morten H ^a   Tabor, Ann ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FETUS DNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENOTYPE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY TERMINATION; PREMATURE LABOR; PRENATAL SCREENING; PRIORITY JOURNAL; SPONTANEOUS PRETERM DELIVERY;

ADULT; CASE-CONTROL STUDIES; DELIVERY, OBSTETRIC; DNA; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; FETUS; GESTATIONAL AGE; HUMANS; MOTHERS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREMATURE BIRTH; RISK FACTORS;

EID: 84865702441     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.3917     Document Type: Article

References (26)

1. Wen SW, Smith G, Yang Q, Walker M. Epidemiology of preterm birth and neonatal outcome. Semin Fetal Neonatal Med 2004;9(6):429-35.
2. Damus K. Prevention of preterm birth: a renewed national priority. Curr Opin Obstet Gynecol 2008;20(6):590-6.
3. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350(9076):485-7.
4. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999;64(1):218-24.
5. Illanes S, Parra M, Serra R, et al. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction. Prenat Diagn 2009;29(12):1118-22.
6. Alberry MS, Maddocks DG, Hadi MA, et al. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction. Am J Obstet Gynecol 2009;200(1):98-6.
7. Hahn S, Huppertz B, Holzgreve W. Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation? Placenta 2005;26(7):515-26.
8. Farina A, LeShane ES, Romero R, et al. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2005;193(2):421-5.
9. Leung TN, Zhang J, Lau TK, Hjelm NM, Lo YM. Maternal plasma fetal DNA as a marker for preterm labour. Lancet 1998;352(9144):1904-5.
10. Clausen FB, Christiansen M, Steffensen R, et al. Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion 2012;52(4):752-8.
11. Moster D, Lie RT, Markestad T. Long-term medical and social consequences of preterm birth. N Engl J Med 2008;359(3):262-73.
12. Saigal S, den Ouden L, Wolke D, et al. School-age outcomes in children who were extremely low birth weight from four international population-based cohorts. Pediatrics 2003;112(4):943-50.
13. Bhutta AT, Cleves MA, Casey PH, Cradock MM, Anand KJ. Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA 2002;288(6):728-37.
14. Hille ET, den Ouden AL, Saigal S, et al. Behavioural problems in children who weigh 1000g or less at birth in four countries. Lancet 2001;357(9269):1641-3.
15. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR. Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med 2000;343(6):378-84.
16. Roussounis SH, Hubley PA, Dear PR. Five-year-follow-up of very low birthweight infants: neurological and psychological outcome. Child Care Health Dev 1993;19(1):45-59.
17. Illanes S, Gomez R, Fornes R, et al. Free fetal DNA levels in patients at risk of preterm labour. Prenat Diagn 2011;31(11):1082-5.
18. Hahn S, Rusterholz C, Hosli I, Lapaire O. Cell-free nucleic acids as potential markers for preeclampsia. Placenta 2011;32(Suppl):S17-S20.
19. Arias F, Rodriquez L, Rayne SC, Kraus FT. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993;168(2):585-91.
20. Kim YM, Bujold E, Chaiworapongsa T, et al. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2003;189(4):1063-9.
21. Kim YM, Chaiworapongsa T, Gomez R, et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002;187(5):1137-42.
22. Misra VK, Hobel CJ, Sing CF. Placental blood flow and the risk of preterm delivery. Placenta 2009;30(7):619-24.
23. Mi LS, Romero R, Park JW, et al. The clinical significance of a positive Amnisure test() in women with preterm labor. J Matern Fetal Neonatal Med 2012.
24. Farina A, Sekizawa A, Sugito Y, et al. Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients. Prenat Diagn 2004;24(2):83-6.
25. Holzgreve W, Li JJ, Steinborn A, et al. Elevation in erythroblast count in maternal blood before the onset of preeclampsia. Am J Obstet Gynecol 2001;184(2):165-8.
26. Jansen MW, Korver-Hakkennes K, van Leenen D, et al. Significantly higher number of fetal cells in the maternal circulation of women with pre-eclampsia. Prenat Diagn 2001;21(12):1022-6.